Feasibility of N-Acetylcysteine for loss of control eating: an open-label study

Not Applicable

• Conditions: loss of control eating; Mental Health - Eating disorders

• Registration Number: ACTRN12622000902796
• Lead Sponsor: Florey Institute of Neuroscience and Mental Health

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-06-24
• Last Update Posted: 9 August 2022

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 36

Inclusion Criteria

Adult (age >18 years) with loss of control eating, defined as at least one episode of loss of control eating in the past month as assessed using the Eating Loss of Control Scale
- Negative pregnancy test at baseline for participants of childbearing potential

Exclusion Criteria

- Participant with cognitive impairment which will hinder their ability to provide informed consent or to complete the surveys
- Participants who are pregnant or lactating or planning to become pregnant during the study
- Use of any medication containing N-Acetylcysteine or other contraindicated medications within 4 weeks prior to enrolment,
- Known previous hypersensitivity to N-Acetylcysteine
- Any serious medical illness that N-Acetylcysteine may adversely affect.
- Surgery within the past 28 days
- Currently using or planning to use a formal weight loss program during the study

Study & Design

• Study Type: Interventional
• Study Design: Not specified